ZMD Zoommed Inc

ZoomMed inc. (TSX VENTURE:ZMD) developer of e-Pic communication network through the ZRx Prescriber, wishes to inform its shareholders of several new contracts and renewing existing contracts, with many major pharmaceutical companies for the use of its communication chanel for pharmacological information.

Since the beginning of our fiscal year 2012, June 1st, 2011, the backlog value of pharmaceutical contracts, already totaling more than $2,460,000. These contracts fall into two categories, namely: the renewal of contracts from our fiscal year 2011 totaling $1,580,000 and $880,000 in new contracts. During all fiscal year 2011, total backlog was $ 2,100,000. New orders in the amount of $880,000 have been realized since September 1st, this in only 45 days. In just a few weeks we went, on our tool, from 36 to 50 programs, an increase of 38%. To date, 15 major pharmaceutical companies currently use the services of our e-Pic communication chanel.

"New drugs are continuously being introduced. Unfortunately, physicians are overworked and have even less time to meet with pharmaceutical representatives. The wireless Internet connections and increased use of smartphones allow the growth of solutions previously unimaginable. The e-Pic communication network is definitely recognized as a preferred solution, giving an added value to the communication efforts of small and large pharmaceutical companies that seek to reach physicians. In addition, the U.S. market, we have acceded in 2011, confirms the same tendency." Said Mr. Yves Marmet, President and CEO of ZoomMed.

About ZoomMed

ZoomMed developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch(TM), IPhone(TM), IPad(TM), Google Android(TM), other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR). Furthermore, ZoomMed also offers "PraxisLab" a new application that enhances all aspects of the prescription filling process and the complete pharmacists patient file management. PraxisLab uses state-of-the-art protocols and up-to-date software standards, allowing high compatibility with existing software, as well as new generation software.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts: ZoomMed Mr. Yves Marmet President and Chief Executive Officer (450) 678-5457, ext 228info@zoommed.comwww.zoommed.com

Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024